YTS109 / BriSTAR Immunotech - LARVOL DELTA

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases (clinicaltrials.gov) - P1 | N=18 | Not yet recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.

New P1 trial • ANCA Vasculitis • Genetic Disorders • Glomerulonephritis • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Myositis • Nephrology • Sjogren's Syndrome • Systemic Lupus Erythematosus • Vasculitis

Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases (clinicaltrials.gov) - P1 | N=18 | Not yet recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.

New P1 trial • ANCA Vasculitis • Genetic Disorders • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Myositis • Scleroderma • Sjogren's Syndrome • Systemic Lupus Erythematosus • Systemic Sclerosis • Vasculitis

Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial. (PubMed, Nat Med) - P=N/A | "These results demonstrate that YTS109 induced immune resetting and clinical remission, including renal structural restoration, potentially offering a promising therapy for refractory SLE with severe lupus nephritis, pending further validation. ClinicalTrials.gov registration: NCT06379646 ."

Journal • P1 data • Glomerulonephritis • Graft versus Host Disease • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Oncology • Systemic Lupus Erythematosus • HLA-B

A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia (clinicaltrials.gov) - P1 | N=7 | Recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.

New P1 trial • Anemia • Autoimmune Hemolytic Anemia • Hematological Disorders • Immunology

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases (clinicaltrials.gov) - P1 | N=12 | Recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • ANCA Vasculitis • Genetic Disorders • Hematological Disorders • Immunology • Inflammation • Inflammatory Arthritis • Lupus • Myositis • Rheumatoid Arthritis • Rheumatology • Scleroderma • Sjogren's Syndrome • Systemic Lupus Erythematosus • Systemic Sclerosis • Vasculitis

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases (clinicaltrials.gov) - P1 | N=18 | Not yet recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.

New P1 trial • ANCA Vasculitis • Genetic Disorders • Glomerulonephritis • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Myositis • Nephrology • Systemic Lupus Erythematosus • Vasculitis

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases (clinicaltrials.gov) - P1 | N=18 | Not yet recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.

New P1 trial • ANCA Vasculitis • Genetic Disorders • Glomerulonephritis • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Myositis • Nephrology • Scleroderma • Systemic Lupus Erythematosus • Systemic Sclerosis • Vasculitis

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases (clinicaltrials.gov) - P1 | N=12 | Not yet recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.

New P1 trial • ANCA Vasculitis • Genetic Disorders • Hematological Disorders • Immunology • Inflammation • Inflammatory Arthritis • Lupus • Myositis • Rheumatoid Arthritis • Rheumatology • Scleroderma • Sjogren's Syndrome • Systemic Lupus Erythematosus • Systemic Sclerosis • Vasculitis

A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus (clinicaltrials.gov) - P1 | N=36 | Recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Glomerulonephritis • Hematological Disorders • Immune Thrombocytopenic Purpura • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Systemic Lupus Erythematosus • Thrombocytopenia • Thrombocytopenic Purpura

An Clinical Study of YTS109 Cell Injection in Subjects With Refractory Systemic Lupus Erythematosus (clinicaltrials.gov) - P1 | N=36 | Not yet recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.

New P1 trial • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus • Thrombocytopenia

A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia (clinicaltrials.gov) - P1 | N=7 | Not yet recruiting | Sponsor: Institute of Hematology & Blood Diseases Hospital, China

New P1 trial • Anemia • Autoimmune Hemolytic Anemia • Hematological Disorders • Immunology

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease (clinicaltrials.gov) - P=N/A | N=6 | Recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • ANCA Vasculitis • Genetic Disorders • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Myositis • Scleroderma • Sjogren's Syndrome • Systemic Lupus Erythematosus • Systemic Sclerosis • Vasculitis

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease (clinicaltrials.gov) - P=N/A | N=6 | Not yet recruiting | Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.

New trial • ANCA Vasculitis • Fibrosis • Genetic Disorders • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Myositis • Scleroderma • Sjogren's Syndrome • Systemic Lupus Erythematosus • Systemic Sclerosis • Vasculitis